Alternative Medicine Maryland’s lawsuit is the second legal challenge seeking to overturn the commission’s preliminary decision in August on which 15 companies will grow the drug.
Alternative Medicine Maryland’s lawsuit is the second legal challenge seeking to overturn the commission’s preliminary decision in August on which 15 companies will grow the drug.